Patients using the Boston Scientific Latitude remote patient management system with wireless telemetry demonstrated significantly lower mortality and fewer hospitalisations than patients with Latitude-compatible devices who were not followed on the system, according to results from the PREDICt-RM study (Patient related determinants of ICD remote monitoring utilisation and outcomes). The results were presented at the Heart Rhythm Society’s 35th Annual Scientific Sessions (7–10 May, San Francisco, USA).
PREDICt-RM demonstrated a 33% relative reduction in the risk of death in patients with Boston Scientific ICDs and CRT-Ds who were remotely monitored via the Latitude wireless remote monitoring system, compared to Boston Scientific ICD and CRT-D patients who were not remotely monitored. Additionally, these patients experienced a 19% relative reduction in hospitalisations for any cause. The study outcomes were presented by Joseph Akar, associate professor of medicine at Yale University and the Center for Outcomes Research and Evaluation (CORE) in New Haven, USA, and are a result of a research collaboration between Yale CORE, the American College of Cardiology (ACC) and Boston Scientific.
“The PREDICt-RM results demonstrate improved outcomes for those ICD and CRT-D patients using the Latitude wireless remote patient management system,” says Joseph Akar. “Despite the widespread availability of this technology, we know that it is underutilised. Our hope is that this study may inform clinical practice guidelines and promote the routine use of this technology in daily practice.”
PREDICt-RM builds on Boston Scientific’s innovation and leadership in clinical science. These results were made possible via a unique research design that linked three large health care databases, illuminating the potential for “big data” and healthcare analytics to advance patient care. PREDICt-RM combined the National Cardiovascular Data Registry (NCDR) from ACC, CMS data from Medicare, and the Boston Scientific Latitude system.